1991 - ANZSBT History Project

Term ‘evidence-based-medicine’ 1^st proposed with some controversy over its attribution: Eddy or Guyatt. Guyatt G. (Evidence-based medicine. ACP Journal Club. 1991;114(2): A16.

Filgrastim (Neupogen) FDA approved for treatment of cancer patients receiving chemotherapy reducing risk of neutropenic infection (pictured).

The Australian & New Zealand Society of Blood Transfusion (ANZSBT) aims to engage with stakeholders in all areas of transfusion through communication, representation and advocacy.

Get Involved

Explore

Suggest an Edit

The History Committee has made every effort to source & record accurate facts, dates & figures.

Source materials, especially older texts, have been of variable integrity & we welcome notification of any corrections which will improve the accuracy of our historical story.

Suggest an edit